| 12358909 |
Capsazepine analogs for the treatment of cancer and other proliferative diseases |
Cara B. GONZALES |
2025-07-15 |
| 12145913 |
Inhibition of Olig2 activity |
Graham Beaton, Ambrosio Lopez, Jr., Bismarck CAMPOS, Hua Wang |
2024-11-19 |
| 12071409 |
Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereof |
Stanley Watowich, Harshini Neelakantan, Hua Wang |
2024-08-27 |
| 11952330 |
Antibiotic ammonium compounds and methods for the treatment of bacterial infections |
Bryan Davies, Ashley Cunningham, Hua Wang |
2024-04-09 |
| 11691951 |
Inhibition of Olig2 activity |
Graham Beaton, Fabio Tucci, Satheesh B. Ravula, Francisco Xavier RUIZ, Ambrosio Lopez, Jr. +2 more |
2023-07-04 |
| 11685722 |
Inhibition of Olig2 activity |
Graham Beaton, Ambrosio Lopez, Jr., Bismarck CAMPOS, Hua Wang |
2023-06-27 |
| 11492331 |
Redox substrates for leukocyte esterase |
Waldemar Gorski, Douglas Hanson, Travis Menard, Andrew FLEISCHMAN |
2022-11-08 |
| 11401243 |
Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereof |
Stanley Watowich, Harshini Neelakantan, Hua Wang |
2022-08-02 |
| 11304916 |
Methods and compositions for the treatment of Shiga Toxicosis |
Somshuvra Mukhopadhyay, Andrey S. Selyunin |
2022-04-19 |
| 11242323 |
Inhibition of OLIG2 activity |
Graham Beaton, Ambrosio Lopez, Jr., Bismarck CAMPOS, Hua Wang |
2022-02-08 |
| 10457676 |
Capsazepine analogs for the treatment of cancer and other proliferative diseases |
Cara B. GONZALES |
2019-10-29 |
| 9169220 |
Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors |
Richard M. Corbett, Donald M. Maxwell, Michael Wade Tidwell, Bismarck CAMPOS, Christopher J. Bemben |
2015-10-27 |
| 8772345 |
Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors |
Richard M. Corbett, Donald M. Maxwell, Michael Wade Tidwell, Bismarck CAMPOS, Christopher J. Bemben |
2014-07-08 |
| 8653108 |
Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors |
Richard M. Corbett, Donald M. Maxwell, Michael Wade Tidwell, Bismarck CAMPOS, Christopher J. Bemben |
2014-02-18 |
| 8124639 |
Bicyclic [3.1.0] heteroaryl amides as type 1 glycine transport inhibitors |
John A. Lowe, III |
2012-02-28 |
| RE40838 |
2-azabicyclo[3.3.1]nonane derivatives |
Jotham Wadsworth Coe |
2009-07-07 |
| 7473787 |
Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
John A. Lowe, III |
2009-01-06 |
| 7241887 |
3-azabicyclo[3.2.1]octane derivatives |
Jotham Wadsworth Coe, Crystal G. Bashore |
2007-07-10 |
| 7129263 |
Preparation of 3-azabicyclo [3.1.0] hexane derivatives |
John Ragan, Derek Tickner, Brian C. Vanderplas, Jotham Wadsworth Coe |
2006-10-31 |
| 7056930 |
2-Azabicyclo[3.3.1]nonane derivatives |
Jotham Wadsworth Coe |
2006-06-06 |
| 7049335 |
3-azabicyclo[3.1.0]hexane derivatives |
Spiros Liras, Steven Heck |
2006-05-23 |
| 6960609 |
1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
Michael Vetelino |
2005-11-01 |
| 6444679 |
4-phenyl-4-heteroarylpiperidine derivatives |
Spiros Liras |
2002-09-03 |
